Kombucha tea improves glucose tolerance and reduces hepatic steatosis in obese mice.
Gabriela V Moreira, Layanne C C Araujo, Gilson M Murata...
https://pubmed.ncbi.nlm.nih.gov/36095960Actively Recruiting
Led by Associação Centro de Apoio Tecnológico Agro Alimentar · Updated on 2025-01-06
33
Participants Needed
2
Research Sites
20 weeks
Total Duration
Researchers are investigating the effects of kombucha, a fermented tea beverage, on individuals who are overweight or have class 1 obesity. The study focuses on how kombucha impacts gut microbiota composition, metabolic parameters such as glucose and insulin levels, lipid profiles, and liver function. Previous animal studies suggested potential benefits, but this clinical study aims to provide stronger evidence in humans through a randomized controlled pilot trial. Participants will be randomly assigned to one of three groups: one group will consume 33 cl of live (non-pasteurized, non-filtered) kombucha daily, another will consume 33 cl of pasteurized kombucha daily, and the control group will receive 33 cl of sparkling water daily. Each intervention lasts for 4 weeks (28 days), allowing comparison between the effects of live versus pasteurized kombucha and the control on health markers. During the 4-week study, participants will provide fecal samples to analyze gut microbiota changes and undergo measurements of fasting glucose, insulin levels, insulin resistance (HOMA-IR), and lipid profiles. The study will monitor these outcomes to evaluate the metabolic and microbiome effects of kombucha consumption. Participants must comply with the study protocol and attend scheduled assessments throughout the study period.
CONDITIONS
Kombucha in Overweight and Obese: Live Vs. Pasteurized Effects on Microbiota, Metabolism, and Liver Function
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Total: 2 locations
1
Centro de Apoio Tecnológico Agro Alimentar (CATAA)
Castelo Branco, Castelo Branco District, Portugal, 6000-459
Actively Recruiting
2
Centro de Apoio Tecnológico Agro Alimentar (CATAA) (facilities temporarily provided by the Affidea clinical analysis center)
Covilha, Portugal, 6200-077
Actively Recruiting
I
Inês Brandão, PhD
F
Filomena Pereira, Nutritionist
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Gabriela V Moreira, Layanne C C Araujo, Gilson M Murata...
https://pubmed.ncbi.nlm.nih.gov/36095960